Limitation of the antibiotic-eluting bone graft substitute: An example of gentamycin-impregnated calcium sulfate

Chang Chin Wu, Yang Kai Huang, Wei Jen Chang, Yun Ching Wu, Chen Chie Wang, Kai Chiang Yang

Research output: Contribution to journalArticle

Abstract

Patients with inadequate volume of alveolar processes or bone defects commonly require graft substitutes in oral, maxillofacial or orthopedic surgery. Ridge augmentation and reconstruction of facial bony defects with bone graft materials achieve better outcomes in functional and aesthetic rehabilitation. The injectable calcium sulfate filler is used widely in intra-operative applications. Calcium sulfate bone filler has been shown to upregulate bone formation-related mRNA genes in vitro and improve osseointegration in vivo. In addition, the bone graft substitute can be used as a drug delivery system for antibiotics to treat or prevent infections based on the clinical experiences. However, the influences of antibiotics addition on the calcium sulfate are not fully understood. In this study, calcium sulfate impregnated with gentamycin in different weight ratios was characterized. The results showed that gentamycin prolonged the hydration process and extended initial/final setting times of calcium sulfate. The addition of gentamycin slowed the conversion from calcium sulfate hemihydrate to dihydrate and changed the crystalline phase and microstructure. Higher amounts of gentamycin added resulted in faster degradation and lower mechanical strength of calcium sulfate. This study reveals that the extended setting time, decreased compressive strength, and the accelerated degradation of the gentamycin-impregnated calcium sulfate bone graft substitutes should be considered during intra-operative applications.

Original languageEnglish
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
DOIs
Publication statusPublished - 2018
Externally publishedYes

Fingerprint

Calcium Sulfate
Antibiotics
Gentamicins
Grafts
Calcium
Bone
Anti-Bacterial Agents
Fillers
Degradation
Defects
Sulfates
Orthopedics
Patient rehabilitation
Hydration
Surgery
Compressive strength
Strength of materials
Genes
Crystalline materials
Messenger RNA

Keywords

  • Bone defect
  • Bone substitute
  • Calcium sulfate
  • Gentamycin
  • Infection

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering

Cite this

@article{2a9dfb9950114ee7a382c7bb868cf6f1,
title = "Limitation of the antibiotic-eluting bone graft substitute: An example of gentamycin-impregnated calcium sulfate",
abstract = "Patients with inadequate volume of alveolar processes or bone defects commonly require graft substitutes in oral, maxillofacial or orthopedic surgery. Ridge augmentation and reconstruction of facial bony defects with bone graft materials achieve better outcomes in functional and aesthetic rehabilitation. The injectable calcium sulfate filler is used widely in intra-operative applications. Calcium sulfate bone filler has been shown to upregulate bone formation-related mRNA genes in vitro and improve osseointegration in vivo. In addition, the bone graft substitute can be used as a drug delivery system for antibiotics to treat or prevent infections based on the clinical experiences. However, the influences of antibiotics addition on the calcium sulfate are not fully understood. In this study, calcium sulfate impregnated with gentamycin in different weight ratios was characterized. The results showed that gentamycin prolonged the hydration process and extended initial/final setting times of calcium sulfate. The addition of gentamycin slowed the conversion from calcium sulfate hemihydrate to dihydrate and changed the crystalline phase and microstructure. Higher amounts of gentamycin added resulted in faster degradation and lower mechanical strength of calcium sulfate. This study reveals that the extended setting time, decreased compressive strength, and the accelerated degradation of the gentamycin-impregnated calcium sulfate bone graft substitutes should be considered during intra-operative applications.",
keywords = "Bone defect, Bone substitute, Calcium sulfate, Gentamycin, Infection",
author = "Wu, {Chang Chin} and Huang, {Yang Kai} and Chang, {Wei Jen} and Wu, {Yun Ching} and Wang, {Chen Chie} and Yang, {Kai Chiang}",
year = "2018",
doi = "10.1002/jbm.b.33815",
language = "English",
journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",
issn = "1552-4973",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Limitation of the antibiotic-eluting bone graft substitute

T2 - An example of gentamycin-impregnated calcium sulfate

AU - Wu, Chang Chin

AU - Huang, Yang Kai

AU - Chang, Wei Jen

AU - Wu, Yun Ching

AU - Wang, Chen Chie

AU - Yang, Kai Chiang

PY - 2018

Y1 - 2018

N2 - Patients with inadequate volume of alveolar processes or bone defects commonly require graft substitutes in oral, maxillofacial or orthopedic surgery. Ridge augmentation and reconstruction of facial bony defects with bone graft materials achieve better outcomes in functional and aesthetic rehabilitation. The injectable calcium sulfate filler is used widely in intra-operative applications. Calcium sulfate bone filler has been shown to upregulate bone formation-related mRNA genes in vitro and improve osseointegration in vivo. In addition, the bone graft substitute can be used as a drug delivery system for antibiotics to treat or prevent infections based on the clinical experiences. However, the influences of antibiotics addition on the calcium sulfate are not fully understood. In this study, calcium sulfate impregnated with gentamycin in different weight ratios was characterized. The results showed that gentamycin prolonged the hydration process and extended initial/final setting times of calcium sulfate. The addition of gentamycin slowed the conversion from calcium sulfate hemihydrate to dihydrate and changed the crystalline phase and microstructure. Higher amounts of gentamycin added resulted in faster degradation and lower mechanical strength of calcium sulfate. This study reveals that the extended setting time, decreased compressive strength, and the accelerated degradation of the gentamycin-impregnated calcium sulfate bone graft substitutes should be considered during intra-operative applications.

AB - Patients with inadequate volume of alveolar processes or bone defects commonly require graft substitutes in oral, maxillofacial or orthopedic surgery. Ridge augmentation and reconstruction of facial bony defects with bone graft materials achieve better outcomes in functional and aesthetic rehabilitation. The injectable calcium sulfate filler is used widely in intra-operative applications. Calcium sulfate bone filler has been shown to upregulate bone formation-related mRNA genes in vitro and improve osseointegration in vivo. In addition, the bone graft substitute can be used as a drug delivery system for antibiotics to treat or prevent infections based on the clinical experiences. However, the influences of antibiotics addition on the calcium sulfate are not fully understood. In this study, calcium sulfate impregnated with gentamycin in different weight ratios was characterized. The results showed that gentamycin prolonged the hydration process and extended initial/final setting times of calcium sulfate. The addition of gentamycin slowed the conversion from calcium sulfate hemihydrate to dihydrate and changed the crystalline phase and microstructure. Higher amounts of gentamycin added resulted in faster degradation and lower mechanical strength of calcium sulfate. This study reveals that the extended setting time, decreased compressive strength, and the accelerated degradation of the gentamycin-impregnated calcium sulfate bone graft substitutes should be considered during intra-operative applications.

KW - Bone defect

KW - Bone substitute

KW - Calcium sulfate

KW - Gentamycin

KW - Infection

UR - http://www.scopus.com/inward/record.url?scp=85002886040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002886040&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.33815

DO - 10.1002/jbm.b.33815

M3 - Article

AN - SCOPUS:85002886040

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

SN - 1552-4973

ER -